(Q35327402)

7 August 2017

1 reference

title

Gut microbiome and nonalcoholic fatty liver diseases (English)

1 reference

7 August 2017

0 references

Lixin Zhu

1

1 reference

7 August 2017

Robert D Baker

series ordinal

2

1 reference

7 August 2017

Susan S Baker

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

13 October 2014

1 reference

7 August 2017

1 reference

7 August 2017

77

1 reference

7 August 2017

1-2

1 reference

7 August 2017

245-251

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2014.157

7 August 2017

0 references

cites work

Enterotypes of the human gut microbiome

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

The role of the gut microbiota in nutrition and health.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

The role of pH in determining the species composition of the human colonic microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Obesity alters gut microbial ecology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Microbial ecology: human gut microbes associated with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Human colonic microbiota associated with diet, obesity and weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Human gut microbiota in obesity and after gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Microbiota and SCFA in lean and overweight healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Early differences in fecal microbiota composition in children may predict overweight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

An obesity-associated gut microbiome with increased capacity for energy harvest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Comparative genome analysis of Prevotella ruminicola and Prevotella bryantii: insights into their environmental niche.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Linking long-term dietary patterns with gut microbial enterotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Fecal short-chain fatty acids in children with inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Extrahepatic, differential expression of four classes of human alcohol dehydrogenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

The formation of ethanol in Escherichia coli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Role of alcohol metabolism in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

In-feed antibiotic effects on the swine intestinal microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Toll-like receptors and their role in gastrointestinal disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Metabolic endotoxemia initiates obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Elevated endotoxin levels in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

A core gut microbiome in obese and lean twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

Studies of metabolites in diarrheal stool specimens containing Shigella species by frequency-pulsed electron capture gas-liquid chromatography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.157

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/PR.2014.157

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference